CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
https://doi.org/10.22625/2072-6732-2018-10-1-113-120
Abstract
On the example of clinical observation of severe respiratory syncytial virus (RSV) infection, which occurred with the development of a specific pneumonia complicated by acute respiratory distress-syndrome and disseminated intravascular coagulation syndrome, which caused a lethal outcome in the non-term (33-34 weeks gestation) child of two months of life, the clinical and pathomorphological features of the disease are shown. Immunomorphologic study after death allowed to demonstrate the most important stages of respiratory syncytial viral infection pathogenesis and to specify reasons of long-term airway obstruction, caused by complicated respiratory syncytial viral infection. It was indicated, that bronchial obstruction may be caused by qualitative changes of epithelial lumen of different bronchi, such as direct cytophatic effect of respiratory virus or reactive changes of lumen in the form of basal squamous cell differentiation of epithelial lumen and poor regeneration of respiratory epithelium in the later stages of the disease.
About the Authors
I. V. BabachenkoRussian Federation
V. E. Karev
Russian Federation
K. V. Evdokimov
Russian Federation
References
1. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012 May; 54 (10): 1427-1436.
2. Scheltema NM, Gentile A, Lucion F, Nokes DJ, Munywoki PK, et al. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017 Oct; 5: e984–91.
3. Geoghegan S., Erviti A., Caballero M. T.; Vallone F., Zanone S. M. Mortality due to respiratory syncytial virus: burden and risk factors. AJRCCM Articles in Press. Published on 22- June-2016 as 10.1164/rccm.201603-0658OC.
4. Rovnyj V.B., Ibragimova O.M., Lobzin Yu.V., Babachenko I.V. Detskie infekcii. 2013; 12 (4):19-23 (in Russian).
5. Cinzerling A.V., Cinzerling V.A. Modern infections. Pathological anatomy and pathogenesis questions. Saint-Petersburg, SOTIS; 2007 (in Russian).
6. Jumat MR, Yan Y, Ravi IL, Wong P, Huong TN, et al. Morphogenesis of respiratory syncytial virus in human primary nasal ciliated epithelial cells occurs at surface membrane microdomains that are distinct from cilia. Virology. 2015 Oct; 484:395-411.
7. Zhai S, Hu L, Zhong L, Guo Y, Dong L, et al. Respiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal Injury. Frontiers in Cellular and Infection Microbiology. 2016 Sept; 6:112.
8. Fleming EH, Ochoa EE, Nichols JE, O’Banion MK, Salkind AR, Roberts NJ. Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus. J.Med.Virol. 2018 Jan; 90(1):26-33.
9. Evdokimov K.V., Rovnyj V.B., Babachenko I.V., Sharipova E.V. Medicinskij sovet. 2017; 4:7-10 (in Russian).
Review
For citations:
Babachenko I.V., Karev V.E., Evdokimov K.V. CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT. Journal Infectology. 2018;10(1):113-120. (In Russ.) https://doi.org/10.22625/2072-6732-2018-10-1-113-120